Article info

Original research
High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignancies

Authors

  • Özcan Çınar Department of Hematology, Oncology and Tumor Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany PubMed articlesGoogle scholar articles
  • Bernadette Brzezicha Experimental Pharmacology and Oncology Berlin-Buch GmbH (EPO), Berlin, Germany PubMed articlesGoogle scholar articles
  • Corinna Grunert Department of Hematology, Oncology and Tumor Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany PubMed articlesGoogle scholar articles
  • Peter Michael Kloetzel Institute of Biochemistry, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany PubMed articlesGoogle scholar articles
  • Christin Beier Institute of Biochemistry, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany PubMed articlesGoogle scholar articles
  • Caroline Anna Peuker Department of Hematology, Oncology and Tumor Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany PubMed articlesGoogle scholar articles
  • Ulrich Keller Department of Hematology, Oncology and Tumor Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany PubMed articlesGoogle scholar articles
  • Antonio Pezzutto Department of Hematology, Oncology and Tumor Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany PubMed articlesGoogle scholar articles
  • Antonia Busse Department of Hematology, Oncology and Tumor Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Özcan Çınar; oezcan.cinar{at}charite.de
View Full Text

Citation

Çınar Ö, Brzezicha B, Grunert C, et al
High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignancies

Publication history

  • Accepted July 9, 2021
  • First published July 30, 2021.
Online issue publication 
November 02, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.